Kolbe, 2016 - Google Patents
New carbohydrate derivatives as tools to bind and metabolically label strains of the Mycobacterium tuberculosis complexKolbe, 2016
View PDF- Document ID
- 13887175434146347068
- Author
- Kolbe K
- Publication year
External Links
Snippet
Abstract Tuberculosis (Tb), caused by Mycobacterium tuberculosis (Mtb), is the single leading bacterial cause of death from infectious diseases worldwide. Tb therapy is complicated by an increase in antibiotic resistant Mtb strains and the lack of fast and specific …
- 241001302239 Mycobacterium tuberculosis complex 0 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/08—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium
- C07H5/10—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium to sulfur
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kong et al. | An antibacterial vaccination strategy based on a glycoconjugate containing the core lipopolysaccharide tetrasaccharide Hep 2 Kdo 2 | |
Houde et al. | Streptococcus suis capsular polysaccharide inhibits phagocytosis through destabilization of lipid microdomains and prevents lactosylceramide-dependent recognition | |
Decout et al. | Deciphering the molecular basis of mycobacteria and lipoglycan recognition by the C-type lectin Dectin-2 | |
Boltje et al. | Chemical synthesis and immunological evaluation of the inner core oligosaccharide of Francisella tularensis | |
Holzheimer et al. | Chemical synthesis of cell wall constituents of Mycobacterium tuberculosis | |
Zorzoli et al. | Group A, B, C, and G Streptococcus Lancefield antigen biosynthesis is initiated by a conserved α-D-GlcNAc-β-1, 4-L-rhamnosyltransferase | |
Giguère | Surface polysaccharides from Acinetobacter baumannii: Structures and syntheses | |
Umesiri et al. | Recent advances toward the inhibition of mAG and LAM synthesis in Mycobacterium tuberculosis | |
Lorenzo et al. | Chemistry and biology of the potent endotoxin from a Burkholderia dolosa clinical isolate from a cystic fibrosis patient | |
Pei et al. | Interplay between carbohydrate and lipid in recognition of glycolipid antigens by natural killer T cells | |
Daher et al. | Glycopeptidolipid glycosylation controls surface properties and pathogenicity in Mycobacterium abscessus | |
WO2011030160A1 (en) | Detection of mycobacteria | |
McNally et al. | The HS: 19 serostrain of Campylobacter jejuni has a hyaluronic acid‐type capsular polysaccharide with a nonstoichiometric sorbose branch and O‐methyl phosphoramidate group | |
Wenzel et al. | An atypical lipoteichoic acid from Clostridium perfringens elicits a broadly cross-reactive and protective immune response | |
Syal et al. | Synthetic arabinomannan glycolipids impede mycobacterial growth, sliding motility and biofilm structure | |
Kuppala et al. | Synthesis and antibacterial activity of ricinoleic acid glycosides | |
Kolbe et al. | Lectins of Mycobacterium tuberculosis–rarely studied proteins | |
Pohane et al. | A bifunctional chemical reporter for in situ analysis of cell envelope glycan recycling in mycobacteria | |
Kolbe | New carbohydrate derivatives as tools to bind and metabolically label strains of the Mycobacterium tuberculosis complex | |
WO2005120555A1 (en) | Use of human lysozyme in preparation of medicine for treating acne | |
Chambers | Harnessing Human Milk Oligosaccharides and Ellagic Acid Glycosides to Combat Group B Streptococcus | |
Oberli et al. | Synthetic oligosaccharide bacterial antigens to produce monoclonal antibodies for diagnosis and treatment of disease using Bacillus anthracis as a case study | |
Pais | Development of new antibiotics against Bacillus anthracis | |
Jiao | Syntheses of carbohydrate antigens expressed by gastric-intestinal bacteria and conjugates thereof | |
Ali | Synthesis of Complex Sugar Mycolates of Mycobacterium Tuberculosis |